RESUMEN
Hypertrophic lupus erythematosus (HLE) is a distinct and rare clinical variant of chronic cutaneous lupus erythematosus (CCLE). It is characterized by verrucous lesions and a chronic course of disease. HLE tends to be much more refractory to treatment than classical CCLE. Therefore, the traditionally available therapeutic options including sun protection, topical and oral corticosteroids, hydroxychloroquine, retinoid and thalidomide are often unable to control the disease. We report here on the successful use of triamcinolone intralesional injection in a patient with HLE and who failed to respond to conventional treatment such as acitretin and hydroxychloroquine.
Asunto(s)
Humanos , Acitretina , Corticoesteroides , Hidroxicloroquina , Inyecciones Intralesiones , Lupus Eritematoso Cutáneo , Sistema Solar , Talidomida , TriamcinolonaRESUMEN
Hypertrophic lupus erythematosus is a clinical variant of chronic cutaneous lupus erythematosus (CCLE). It is critical to differentiate hypertrophic lupus erythematosus from CCLE because of treatment and prognosis. We report a case of hypertrophic lupus erythematosus with CCLE occured on arms. Combination therapy with acitretin and intralesional corticosteroid injection resulted in control of previously refractory skin lesion.